AI Capital Spending Boom Rivals Historical Peaks Raymond James Strategists Say Monetarism Under Fire Critics Draw Parallels to Soviet Central Planning HighYield Savings Rates on May 23 2026 Top Accounts Offer Up to 41 APY Markets Pivot to Rate Hike Expectations After Hot Inflation Data SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaways Market Value on Debut Traders Predict AIDriven Changes May Reduce IT Workload and Employment Says Genpact CEO SPRO Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Response OnKure Therapeutics OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline NMIH Q1 2026 Earnings EPS Beats Estimates Shares Edge Lower Grupo Aeromexico Q4 2025 Earnings EPS Falls Sharply Short of Estimates as Operational Headwinds Persist Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path DUOL Q1 2026 Earnings EPS Beats Estimates by 164 Stock Edges Higher Arq Inc ARQ Surges 44 Approaching Key Resistance at 273 Glimpse Group Shares Dip as Stock Hovers Near Key Support Levels GGRP Park Ha Biological Technology BYAH Holds Gains as Stock Tests Key Support Zone QuantumScape QS Slides 215 as Stock Tests Key Support Levels SELLAS Life Sciences Group SLS Surges 629 as Biotech Momentum Builds Mustang Bio Inc MBIO Q4 2024 Earnings Massive EPS Miss Amidst No Revenue FOLD Q4 2025 Earnings EPS Falls Short of Estimates Stock Unchanged INDV Q1 2026 Earnings Strong EPS Beat Underscores Operational Discipline CAC Q1 2026 Earnings EPS Beats Estimates Amid Stable Banking Operations CCC Q1 2026 Earnings EPS Surpasses Estimates by Nearly 15 RIO Q4 2025 Earnings EPS Misses Estimates but Stock Rises 26 Micron Reaches 1 Trillion Market Capitalization Amid AIDriven Memory Shortage SWBI Q1 2026 Earnings EPS Surprises Despite Flat Market Reception Sensus Healthcare SRTS Moves Higher Testing Key Resistance Levels